Autoimmune glial fibrillary acidic protein astrocytopathy: case report of a treatable cause of rapidly progressive dementia
- 26 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 268 (6), 2256-2258
- https://doi.org/10.1007/s00415-021-10484-y
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- [18F]-FDG PET imaging in autoimmune GFAP meningoencephalomyelitisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Clinical characteristics of autoimmune GFAP astrocytopathyJournal of Neuroimmunology, 2019
- Autoimmune glial fibrillary acidic protein astrocytopathyCurrent Opinion in Neurology, 2019
- Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective studyEuropean Journal of Neurology, 2018
- Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patientsJournal of Neurology, Neurosurgery & Psychiatry, 2018
- Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patientsAnnals of Neurology, 2017
- Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyJAMA Neurology, 2016
- Relapsing–Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T CellsThe Journal of Immunology, 2014
- Rapidly Progressive Neurodegenerative DementiasArchives of Neurology, 2009